oxycodone articles & resources on Made-in-China.com

Oxycodone and Hydrocodone Are The Most Popular Drugs Among Americans

Dec 26, 2013

Oxycodone -- the active ingredient in OxyContin -- and hydrocodone are the most popular drugs among Americans who abuse prescription painkillers, a new study finds. OxyContin and Percocet are brand names for drugs containing oxycodone. ...

Tags: oxycodone, abuse prescription painkillers, OxyContin, Percocet

QRxPharma Has Resubmitted Its MOXDUO New Drug Application

Nov 29, 2013

QRxPharma, an Australian-based commercial-stage specialty pharmaceutical company, has resubmitted its MOXDUO new drug application (NDA). At a meeting in early October 2013, the US Food and Drug Administration (FDA) provided QRxPharma with ...

Tags: QRxPharma, Drug Application

Collegium Pharmaceutical Has Announced That a Patent Has Been Issued by USPTO

Oct 21, 2013

Collegium Pharmaceutical, a specialty pharmaceutical company, has announced that a patent has been issued by the US Patent and Trademark Office (USPTO) covering its Oxycodone DETERx formulation. Additionally, an application has been ...

Tags: Collegium Pharmaceutical, US Patent

Quest Diagnostics Launches Opioid Therapy Genetic Test Based on CYP450

Aug 15, 2013

Diagnostic information services provider Quest Diagnostics has rolled out its new lab-developed genetic test to support the delivery of modified opioid pain-relieving treatment. It effectively tests for variants in all cytochrome P450 ...

Tags: Quest Diagnostics, Opioid Therapy Genetic Test

Walgreens Has Agreed to Reimburse a Monetary Penalty of $80m to The US DEA

Jun 14, 2013

US-based drug store chain Walgreens has agreed to reimburse a monetary penalty of $80m to the US Drug Enforcement Administration (DEA) to settle the charges of violating federal regulations governing the distribution of prescription ...

Tags: Walgreens, Illegal Prescription

FDA Approved Updated Labeling for Purdue Pharma L.P.'s Reformulated OxyContin Tablets

Apr 25, 2013

Posted by Jack Mans, Plant Operations Editor -- Packaging Digest, 4/23/2013 5:04:22 PM The U.S. Food and Drug Administration today approved updated labeling for Purdue Pharma L.P.'s reformulated OxyContin (oxycodone hydrochloride ...

Tags: Packaging, Printing

USPTO Has Granted Notice of Allowance to Collegium Pharmaceutical's Patent Applicat

Feb 19, 2013

The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to Collegium Pharmaceutical's patent application NO.12/823,628 covering a tamper-resistant, extended-release opioid product. The patent entitled, ...

Tags: USPTO, NOA, Collegium Opioid Product

US FDA Has Approved Watson Pharmaceuticals's ANDA for Oxycodone and Acetaminophen Tablets

Jan 4, 2013

US FDA has approved Watson Pharmaceuticals' abbreviated new drug application (ANDA) for Oxycodone and Acetaminophen tablets, USP 7.5 mg/500 mg and 10 mg/650 mg. The tablets are the generic equivalent to Endo Pharmaceuticals' Percocet ...

Tags: US FDA, ANDA, Watson Pharmaceuticals, Oxycodone and Acetaminophen tablets

Pain Therapeutics Received Four US Patents Covering Remoxy Extended-Release Capsules CII

May 4, 2012

Pain Therapeutics, a biopharmaceutical company, has received four US patents covering Remoxy (oxycodone) extended-release capsules CII. The issued patents are licensed exclusively to Pain Therapeutics in the US and international ...

Tags: Patent, extended-release capsule, pharmaceutical product

oxycodone

Related Products